DOCSLIB.ORG

Abstracts Plenary Session: Before the First 1000 Days: Before Conception and After Birth

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Abstracts Plenary Session: Before the First 1000 Days: Before Conception and After Birth Abstracts Plenary Session: Before the First 1000 Days: Before Conception and After Birth INFLUENCE OF EARLY NUTRITIONAL FACTORS ON OBESITY IN THE OFFSPRING L. Moreno1 1GENUD research group- Universidad de Zaragoza- Instituto Agroalimentario de Aragón IA2 - Instituto de Investigación Sanitaria de Aragón IIS Aragón- Centro de Investigación Biomédi ca en red de Fisiopatología de la Obesidad y Nutrición CIBEROBN- Zaragoza- Spain, Facultad de Ciencias de la Salud, Zaragoza, Spain Childhood obesity is the most prevalent nutritional disorder during childhood. It develops in individuals with a genetic predisposition substrate and the presence of factors related with nutrition, sedentary behaviours and others as short sleep duration. During early periods of life, starting at conception and until the end of the second year, there is a large number of factors that could influence the development of obesity later in life: pre-pregnancy maternal body mass index (BMI), gestational weight gain, gestational diabetes, maternal malnutrition, maternal smoking during pregnancy, alcohol consumption during pregnancy, free sugars intake during pregnancy, low polyunsaturated fat (omega 3) intake during pregnancy, low physical activity levels during pregnancy, antibiotics consumption during pregnancy, high or low body weight at birth, lack of breast feeding, consumption of high protein content infant formulas, rapid infant weight gain, high protein, fat or free sugars intake during infancy, early introduction of complementary feeding and short sleep duration. From all these candidate risk factors, the ones more strongly associated with obesity development during childhood are maternal obesity before pregnancy, low birth weight and rapid weight gain during infancy. Perinatal factors also influence the expression of some genes related with obesity development. For instance, birth weight modifies the effect of the FTO gene polymorphism in the development of obesity and breastfeeding also modulate the effect of the PPAR-gamma 2 gene polymorphism on the excess of adiposity in adolescents. Interventions trying to prevent obesity should start as early as possible as the possibility to positively influence the early programming of the condition is optimal in this period. Plenary Session: Before the First 1000 Days: Before Conception and After Birth NUTRITION, CONCEPTION AND THE OFFSPRING EPIGENOME M. Silver1 1MRC Unit The Gambia at the London School of Hygiene and Tropical Medicine, Nutrition, London, United Kingdom Our group has a long-standing interest in exploring links between early life nutritional exposures and long-term health outcomes. Much of our research centres on a rural community in The Gambia in Sub-Saharan West Africa. A key focus is on epigenetics - the study of modifications to the genome that can affect gene expression without altering the underlying DNA sequence. Mounting evidence from animal and human studies suggests such modifications may mediate observed associations between early-life nutrition and later health and disease. For our epigenetic studies we are able to exploit an ‘experiment of nature’ in rural Gambia whereby fluctuations in energy balance and maternal nutritional exposures show a distinct bimodal seasonal pattern. We have shown for example that season of conception and blood levels of key maternal nutritional biomarkers relating to one-carbon metabolism (B2, B6, cysteine and homocysteine) predict DNA methylation in infants at a number of metastable epialleles (MEs) - genomic regions where methylation is established stochastically in the early embryo, leading to systemic (cross-tissue) inter-individual variation. I will give an overview of our work in this area and describe some of the interesting candidate MEs that we have selected for follow up in our population including a region at the POMC gene with links to obesity in children and adults. Plenary Session: Before the First 1000 Days: Before Conception and After Birth BREAST FEEDING AND GROWTH K.F. Michaelsen1 1Department of Nutrition- Exercise and Sports, University of Copenhagen, Denmark, Denmark Breastfeeding has a marked effect on early growth and there are some indications that there are also effects on growth later in life. Breastfed infants grow faster during the first 2-3 months and have thereafter a slower growth velocity up to the age of about 12 months, compared to infants that are not breastfed. This growth pattern, which is regarded as optimal, is also reflected in differences in body composition. There are studies suggesting a modest reduction in risk of obesity, but some studies show no effect. The vast majority of studies of the effect of breastfeeding on growth are observational and it is therefore difficult to conclude on causality as residual confounding and reverse causation are likely to influence the associations. There is an increasing number of studies examining the association between composition of breastmilk and growth of the infant. Especially the content of macronutrients, human milk oligosaccharides and appetite related hormones seem to have an effect on growth. A better understanding of these associations are likely to improve our understanding on how breastfeeding is regulating short and long term growth. Future studies should include analysis of milk composition and measurements of body composition when possible. Furthermore, data should also be analyzed according to sex as several studies have suggested that the association between milk intake and composition and growth is different in boys and girls. Plenary Session: Water, Sanitation and Hygiene (WASH) Interventions to Improve Child Health: Where Do We Go Now? PATHWAYS LINKING WASH AND GROWTH S. Sinharoy1 1Emory University, Environmental Health, Atlanta, USA The relationship between water, sanitation, and hygiene and child nutrition remains unclear, with mixed results from ecological and intervention studies. This presentation will provide an overview of key components of water, sanitation and hygiene (WaSH) and will outline the mechanisms and pathways through which WaSH may influence child nutritional status. Specifically, poor WaSH conditions may lead to diarrhea, environmental enteric dysfunction (a subclinical disorder of the small intestine), and intestinal parasitic infection. These in turn may result in undernutrition through appetite suppression, nutrient loss, malabsorption, and inflammation. Our understanding of these mechanisms provides a strong theoretical rationale for combining WaSH interventions to improve child nutrition. To illustrate how these relationships may operate in a real-world setting, the presentation will include results from a matched cohort effectiveness evaluation of a combined on-premise piped water and improved sanitation intervention in rural Odisha, India. We collected data in mid-2016 on anthropometry for children under age 5 (N=1826) in 45 intervention and 45 control villages. Children under age 5 living in communities that received the intervention had higher mean height-for-age z-score (HAZ) (+0.17 HAZ, 95% CI:0.03-0.31) compared to children in control villages. A structural modeling equation (SEM) approach quantified the direct and indirect intervention effects on HAZ through a complex system of divergent water, sanitation, and hygiene pathways. The results of the SEM analysis suggest that piped water and sanitation together influenced HAZ, and that both may be necessary for programs to impact child linear growth. Plenary Session: Water, Sanitation and Hygiene (WASH) Interventions to Improve Child Health: Where Do We Go Now? THE SHINE AND WASH BENEFITS TRIALS J. Humphrey1 1Johns Hopkins Bloomberg School of Public Health, International Health- Center for Human Nutrition, Baltimore, USA The WASH Benefits Bangladesh, WASH Benefits Kenya, and Sanitation Infant Feeding Efficacy (SHINE, Zimbabwe) trials were cluster-randomized controlled trials to test the independent and combined effects of improving household water and sanitation/hygiene (WASH) and improving infant diet on child stunting and anemia at 18 mo (SHINE) or 24 mo (WASH Benefits trials). In addition, 7-day prevalence of diarrhea at 12 and 18 or 24 months was a primary outcome of WASH Benefits and secondary outcome of SHINE. Together the three trials included more than 18,000 children; provided free pit latrines, soap, chlorine, and lipid-based micronutrient supplement; delivered behaviour change modules based on years of formative research and pilot testing, and grounded in behaviour change theory, and measured outcomes by standardized and supervised research staff. WASH Benefits included 7 arms [sanitation, handwashing with soap, point of use water chlorination, all these interventions combined (WASH), infant feeding, WASH+infant feeding, and a double sized control arm (passive in Bangladesh, active in Kenya)]. Thus, it was also designed to compare the benefits of single or combined WASH interventions. SHINE was a 2x2 factorial trials (WASH, Infant feeding, WASH+infant feeding, and an active control). In all three trials: • The interventions were delivered with high fidelity and achieved substantial behavior change; • The infant feeding intervention had a modest benefit but WASH had no effect on stunting; • The infant feeding intervention improved haemoglobin but WASH had no effect on haemoglobin concentration. In Bangladesh, all the intervention arms except water chlorination reduced diarrhea by a relative 30-40% from a very low prevalence (~5%); in the two Africa sites there
Load more

Recommended publications
  • N35.12 Postinfective Urethral Stricture, NEC, Female N35.811 Other
    N35.12 Postinfective urethral stricture, NEC, female N35.811 Other urethral stricture, male, meatal N35.812 Other urethral bulbous stricture, male N35.813 Other membranous urethral stricture, male N35.814 Other anterior urethral stricture, male, anterior N35.816 Other urethral stricture, male, overlapping sites N35.819 Other urethral stricture, male, unspecified site N35.82 Other urethral stricture, female N35.911 Unspecified urethral stricture, male, meatal N35.912 Unspecified bulbous urethral stricture, male N35.913 Unspecified membranous urethral stricture, male N35.914 Unspecified anterior urethral stricture, male N35.916 Unspecified urethral stricture, male, overlapping sites N35.919 Unspecified urethral stricture, male, unspecified site N35.92 Unspecified urethral stricture, female N36.0 Urethral fistula N36.1 Urethral diverticulum N36.2 Urethral caruncle N36.41 Hypermobility of urethra N36.42 Intrinsic sphincter deficiency (ISD) N36.43 Combined hypermobility of urethra and intrns sphincter defic N36.44 Muscular disorders of urethra N36.5 Urethral false passage N36.8 Other specified disorders of urethra N36.9 Urethral disorder, unspecified N37 Urethral disorders in diseases classified elsewhere N39.0 Urinary tract infection, site not specified N39.3 Stress incontinence (female) (male) N39.41 Urge incontinence N39.42 Incontinence without sensory awareness N39.43 Post-void dribbling N39.44 Nocturnal enuresis N39.45 Continuous leakage N39.46 Mixed incontinence N39.490 Overflow incontinence N39.491 Coital incontinence N39.492 Postural
    [Show full text]
  • Diseases of the Digestive System (KOO-K93)
    CHAPTER XI Diseases of the digestive system (KOO-K93) Diseases of oral cavity, salivary glands and jaws (KOO-K14) lijell Diseases of pulp and periapical tissues 1m Dentofacial anomalies [including malocclusion] Excludes: hemifacial atrophy or hypertrophy (Q67.4) K07 .0 Major anomalies of jaw size Hyperplasia, hypoplasia: • mandibular • maxillary Macrognathism (mandibular)(maxillary) Micrognathism (mandibular)( maxillary) Excludes: acromegaly (E22.0) Robin's syndrome (087.07) K07 .1 Anomalies of jaw-cranial base relationship Asymmetry of jaw Prognathism (mandibular)( maxillary) Retrognathism (mandibular)(maxillary) K07.2 Anomalies of dental arch relationship Cross bite (anterior)(posterior) Dis to-occlusion Mesio-occlusion Midline deviation of dental arch Openbite (anterior )(posterior) Overbite (excessive): • deep • horizontal • vertical Overjet Posterior lingual occlusion of mandibular teeth 289 ICO-N A K07.3 Anomalies of tooth position Crowding Diastema Displacement of tooth or teeth Rotation Spacing, abnormal Transposition Impacted or embedded teeth with abnormal position of such teeth or adjacent teeth K07.4 Malocclusion, unspecified K07.5 Dentofacial functional abnormalities Abnormal jaw closure Malocclusion due to: • abnormal swallowing • mouth breathing • tongue, lip or finger habits K07.6 Temporomandibular joint disorders Costen's complex or syndrome Derangement of temporomandibular joint Snapping jaw Temporomandibular joint-pain-dysfunction syndrome Excludes: current temporomandibular joint: • dislocation (S03.0) • strain (S03.4) K07.8 Other dentofacial anomalies K07.9 Dentofacial anomaly, unspecified 1m Stomatitis and related lesions K12.0 Recurrent oral aphthae Aphthous stomatitis (major)(minor) Bednar's aphthae Periadenitis mucosa necrotica recurrens Recurrent aphthous ulcer Stomatitis herpetiformis 290 DISEASES OF THE DIGESTIVE SYSTEM Diseases of oesophagus, stomach and duodenum (K20-K31) Ill Oesophagitis Abscess of oesophagus Oesophagitis: • NOS • chemical • peptic Use additional external cause code (Chapter XX), if desired, to identify cause.
    [Show full text]
  • Diagnosis One To
    Diagnosis One-to-One I9cm I9 Long Desc I10cm I10 Long Desc 0010 Cholera due to vibrio cholerae A000 Cholera due to Vibrio cholerae 01, biovar cholerae 0011 Cholera due to vibrio cholerae el tor A001 Cholera due to Vibrio cholerae 01, biovar eltor 0019 Cholera, unspecified A009 Cholera, unspecified 0021 Paratyphoid fever A A011 Paratyphoid fever A 0022 Paratyphoid fever B A012 Paratyphoid fever B 0023 Paratyphoid fever C A013 Paratyphoid fever C 0029 Paratyphoid fever, unspecified A014 Paratyphoid fever, unspecified 0030 Salmonella gastroenteritis A020 Salmonella enteritis 0031 Salmonella septicemia A021 Salmonella sepsis 00320 Localized salmonella infection, unspecified A0220 Localized salmonella infection, unspecified 00321 Salmonella meningitis A0221 Salmonella meningitis 00322 Salmonella pneumonia A0222 Salmonella pneumonia 00323 Salmonella arthritis A0223 Salmonella arthritis 00324 Salmonella osteomyelitis A0224 Salmonella osteomyelitis 0038 Other specified salmonella infections A028 Other specified salmonella infections 0039 Salmonella infection, unspecified A029 Salmonella infection, unspecified 0040 Shigella dysenteriae A030 Shigellosis due to Shigella dysenteriae 0041 Shigella flexneri A031 Shigellosis due to Shigella flexneri 0042 Shigella boydii A032 Shigellosis due to Shigella boydii 0043 Shigella sonnei A033 Shigellosis due to Shigella sonnei 0048 Other specified shigella infections A038 Other shigellosis 0049 Shigellosis, unspecified A039 Shigellosis, unspecified 0050 Staphylococcal food poisoning A050 Foodborne staphylococcal
    [Show full text]
  • Neurodevelopmental Delay: Case Definition & Guidelines for Data Collection, Analysis, and Presentation of Immunization Safety Data
    Vaccine 37 (2019) 7623–7641 Contents lists available at ScienceDirect Vaccine journal homepage: www.elsevier.com/locate/vaccine Neurodevelopmental delay: Case definition & guidelines for data collection, analysis, and presentation of immunization safety data Adrienne N. Villagomez a,b, Flor M. Muñoz c, Robin L. Peterson a,b, Alison M. Colbert a,b, Melissa Gladstone d, Beatriz MacDonald e, Rebecca Wilson a,b, Lee Fairlie f, Gwendolyn J. Gerner g,h, Jackie Patterson i, Nansi S. Boghossian j, Vera Joanna Burton g,h, Margarita Cortés k, Lakshmi D. Katikaneni l, Jennifer C.G. Larson m, Abigail S. Angulo a,b, Jyoti Joshi n, Mirjana Nesin o, Michael A. Padula p, ⇑ Sonali Kochhar q,r,s, Amy K. Connery a,b, , for The Brighton Collaboration Neurodevelopmental Delay Working Group 1 a University of Colorado School of Medicine, Aurora, CO, USA b Children’s Hospital of Colorado, Aurora, CO, USA c Department of Pediatrics, Baylor College of Medicine, Houston, TX, USA d Department of Women and Children’s Health, Institute of Translational Medicine, University of Liverpool, Liverpool, UK e University of New Mexico School of Medicine, Albuquerque, NM, USA f Wits Reproductive Health and HIV Institute, University of the Witwatersrand, Johannesburg, South Africa g Kennedy Krieger Institute, Baltimore, MD, USA h Johns Hopkins University School of Medicine, Baltimore, MD, USA i University of North Carolina School of Medicine, Chapel Hill, NC, USA j Department of Epidemiology and Biostatistics, Arnold School of Public Health, University of South Carolina, Columbia,
    [Show full text]
  • Feeding Referral Forms
    FEEDING THERAPY REFERRAL FORMS Child’s Name: ______________________________________ Date of Birth: __________________________________ Contact Name: ______________________________________ Phone No.: ____________________________________ Measurements Measurement Date Taken Weight lb oz % Height ft in % BMI Past/Existing Referrals and Specialists Referral Type Date of Referral Name of Specialist/Practice Most Recent Swallow Study Concerns First Reported Gastroenterology Dietician Otolaryngologist Pulmonologist Cardiologist Prior Feeding Therapy Additional Information: ______________________________________________________________________________________________________ ______________________________________________________________________________________________________ ______________________________________________________________________________________________________ Professional Therapy Services When & Where You Need Us! www.carolinatherapeutics.com ∙ [email protected] ​ ​ Tel 704.654.8599 ∙ Fax 980.938.6088 ​ ​ FEEDING REFERRAL FORMS Child’s Name: ______________________________________ Date of Birth: __________________________________ Contact Name: ______________________________________ Phone No.: ____________________________________ Commonly Used ICD-10 Codes for Feeding and Swallowing Disorders (Check all that apply) E46 Applicable to malnutrition, not otherwise specified ​ R13.10 Dysphagia, unspecified (NOS) Protein-calorie imbalance NOS F50.82 Avoidant restrictive food intake disorder R13.11 Oral phase dysphagia F84.0
    [Show full text]
  • XI. COMPLICATIONS of PREGNANCY, Childbffith and the PUERPERIUM 630 Hydatidiform Mole Trophoblastic Disease NOS Vesicular Mole Ex
    XI. COMPLICATIONS OF PREGNANCY, CHILDBffiTH AND THE PUERPERIUM PREGNANCY WITH ABORTIVE OUTCOME (630-639) 630 Hydatidiform mole Trophoblastic disease NOS Vesicular mole Excludes: chorionepithelioma (181) 631 Other abnormal product of conception Blighted ovum Mole: NOS carneous fleshy Excludes: with mention of conditions in 630 (630) 632 Missed abortion Early fetal death with retention of dead fetus Retained products of conception, not following spontaneous or induced abortion or delivery Excludes: failed induced abortion (638) missed delivery (656.4) with abnormal product of conception (630, 631) 633 Ectopic pregnancy Includes: ruptured ectopic pregnancy 633.0 Abdominal pregnancy 633.1 Tubalpregnancy Fallopian pregnancy Rupture of (fallopian) tube due to pregnancy Tubal abortion 633.2 Ovarian pregnancy 633.8 Other ectopic pregnancy Pregnancy: Pregnancy: cervical intraligamentous combined mesometric cornual mural - 355- 356 TABULAR LIST 633.9 Unspecified The following fourth-digit subdivisions are for use with categories 634-638: .0 Complicated by genital tract and pelvic infection [any condition listed in 639.0] .1 Complicated by delayed or excessive haemorrhage [any condition listed in 639.1] .2 Complicated by damage to pelvic organs and tissues [any condi- tion listed in 639.2] .3 Complicated by renal failure [any condition listed in 639.3] .4 Complicated by metabolic disorder [any condition listed in 639.4] .5 Complicated by shock [any condition listed in 639.5] .6 Complicated by embolism [any condition listed in 639.6] .7 With other
    [Show full text]
  • Association Between Vitamin D Level and Patients with Cholestasis
    International Journal of Community Medicine and Public Health Anwar MM et al. Int J Community Med Public Health. 2018 May;5(5):1713-1718 http://www.ijcmph.com pISSN 2394-6032 | eISSN 2394-6040 DOI: http://dx.doi.org/10.18203/2394-6040.ijcmph20181675 Original Research Article Association between vitamin D level and patients with cholestasis Manal M. Anwar1*, Ahmed E. Arafa1, Dalia S. Morgan2, Khaled K. Mohamed3 1Department of Public Health and Community Medicine, 2Department of Pediatrics, Faculty of Medicine, Beni-Suef University, Beni-Suef, Egypt 3 Department of Tropical medicine, Beni-Suef General Hospital, Beni-Suef, Egypt Received: 22 February 2018 Accepted: 21 March 2018 *Correspondence: Dr. Manal M. Anwar, E-mail: [email protected] Copyright: © the author(s), publisher and licensee Medip Academy. This is an open-access article distributed under the terms of the Creative Commons Attribution Non-Commercial License, which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited. ABSTRACT Background: Estimate the prevalence of vitamin D deficiency among patients diagnosed with chronic cholestasis and investigates the association between their clinical manifestations and lab results of 25(OH) D levels. Methods: A cross sectional study of 50 patients aged > 3 months up to 18 years, who had medical care in the Beni- Suef University hospital, Beni-Suef governorate, Egypt. All patients were fully investigated including routine labs in addition to 25- [OH] D levels and dual energy X-ray absorptiometry (DXA). Results: Mean age was 6.5±4.5 years. Mean serum 25 (OH) D levels was 37.9±28.2; 30% of patients had 25 (OH) D <20 ng/ml and 26% had 25 (OH) D 20-<30 ng/ml.
    [Show full text]
  • The ICD-10 Classification of Mental and Behavioural Disorders
    The ICD-10 Classification of Mental and Behavioural Disorders Clinical descriptions and diagnostic guidelines World Health Organization -1- Preface In the early 1960s, the Mental Health Programme of the World Health Organization (WHO) became actively engaged in a programme aiming to improve the diagnosis and classification of mental disorders. At that time, WHO convened a series of meetings to review knowledge, actively involving representatives of different disciplines, various schools of thought in psychiatry, and all parts of the world in the programme. It stimulated and conducted research on criteria for classification and for reliability of diagnosis, and produced and promulgated procedures for joint rating of videotaped interviews and other useful research methods. Numerous proposals to improve the classification of mental disorders resulted from the extensive consultation process, and these were used in drafting the Eighth Revision of the International Classification of Diseases (ICD-8). A glossary defining each category of mental disorder in ICD-8 was also developed. The programme activities also resulted in the establishment of a network of individuals and centres who continued to work on issues related to the improvement of psychiatric classification (1, 2). The 1970s saw further growth of interest in improving psychiatric classification worldwide. Expansion of international contacts, the undertaking of several international collaborative studies, and the availability of new treatments all contributed to this trend. Several national psychiatric bodies encouraged the development of specific criteria for classification in order to improve diagnostic reliability. In particular, the American Psychiatric Association developed and promulgated its Third Revision of the Diagnostic and Statistical Manual, which incorporated operational criteria into its classification system.
    [Show full text]
  • Agenda ICD-9-CM COORDINATION and MAINTENANCE COMMITTEE MEETING the Centers for Disease Control/National Center for Health Statis
    Agenda ICD-9-CM COORDINATION AND MAINTENANCE COMMITTEE MEETING The Centers for Disease Control/National Center for Health Statistics HCFA Auditorium 7500 Security Boulevard Baltimore, MD ICD-9-CM Volumes 1 and 2, Diagnoses November 2, 1998 Donnamaria Pickett Co-Chairperson Update on ICD-10-CM Lack of normal physiological development in infants and children and adult failure to thrive (revised proposal) ................................................. pg. 3-4 Impaired fasting glucose/Impaired glucose tolerance .............................. pg. 5 Observation for suspected child abuse/neglect ................................... pg. 6 Food allergy with gastrointestinal and respiratory manifestations ...................pg. 7-8 Human ehrlichiosis ........................................................ pg. 9 Screening for osteoporosis ................................................. pg. 10 Screening for lipoid disorders .............................................. pg. 11 Human bite as an external cause of injury ..................................... pg. 12 Addenda ............................................................ pg. 13-15 Important time frames for ICD-9-CM Coordination and Maintenance ............... pg. 16 1 ICD-9-CM COORDINATION AND MAINTENANCE COMMITTEE MEETING ICD-9-CM Volumes 1 and 2, Diagnoses November 2, 1998 ICD-9-CM Diagnoses Coding Issues: Mailing Address: Centers for Disease Control and Prevention National Center for Health Statistics 6525 Belcrest Road, Room 110 Hyattsville, MD 20782 Donnamaria Pickett: (301) 436-7050
    [Show full text]
  • R 06.83 Snoring R 11.0 Nausea R 11.10 Vomiting, Unspecified R 11.11
    R 06.83 snoring R 11.0 nausea R 11.10 vomiting, unspecified R 11.11 vomiting without nausea R 11.12 projectile vomiting R 11.2 nausea with vomiting R 15.9 Other specified elimination disorder, with fecal symptoms R 15.9 Unspecified elimination disorder, with fecal symptoms R 25.1 tremor R 27.0 ataxia R 27.8 lack of coordination R 29.6 repeated falls R 35.1 nocturia R 35.8 polyuria R 37 sexual function unspecified R 40.0 somnolence R 40.1 stupor R 40.3 persistent vegetative state R 40.4 transient alteration of awareness R 41.0 other specified delirium R 41.0 Disorientation, unspecified R41.1 Anterograde amnesia R41.2 Retrograde amnesia R41.3 Other amnesia R41.4 Neurologic neglect syndrome R41.80 Age related cognitive decline R41.82 Altered mental status, unspecified R41.83 Borderline intellectual functioning R41.840 Attention and concentration deficit R41.841 Cognitive communication deficit R41.842 Visuospatial deficit R41.843 Psychomotor deficit R41.844 Frontal lobe and executive function deficit R41.89 Other symptoms and signs involving cognitive R42 dizziness R44.0 Auditory hallucinations R44.1 Visual hallucinations R44.2 Other hallucinations R44.3 Hallucinations, unspecified R44.8 Other symptoms and signs involving general sensations and perceptions R44.9 Unspecified symptoms and signs involving general sensations and perceptions R45.0 Nervousness R45.1 Restlessness and agitation R45.2 Unhappiness R45.3 Demoralization and apathy R45.4 Irritability and anger R45.5 Hostility R45.6 Violent behavior R45.7 State of emotional shock and stress,
    [Show full text]
  • Original Article Dietary Pattern of Rachitic Children at Selected Geographical Area Yasmin N1, Ahmad SKA2, Sayed MHS3, Khan MH4, Karim MN5
    Bangladesh Med J. 2014 Sep; 43 (3) Original Article Dietary pattern of rachitic children at selected geographical area Yasmin N1, Ahmad SKA2, Sayed MHS3, Khan MH4, Karim MN5 Abstract Introduction Rickets causes bone deformities through the impaired Rickets causes bone deformities through the impaired mineralization of actively growing bone affecting young mineralization of actively growing bone.1 Ricket is a children in developing countries and frequently found in disease of young children in developing countries and Africa, Asia and Middle Eastern countries. This cross frequently found in Africa, Asia and Middle Eastern sectional study was conducted with a view to assess the dietary countries. Recent report even claimed that there were pattern among the rachitic children among the 151 subjects 5,000,000 affected children in Bangladesh. Nutritional of 3 north-eastern districts of Bangladesh. Out of 151 rickets is a disorder of growing children due to defective subjects 52 were having at least one visible sign of rickets and mineralization of newly formed bone matrix because of considered as rickets case. Rest of the subjects was from their vitamin D deficiency and also calcium deficiency.² The neighborhoods with no such symptoms or sign. More than main source of vitamin D is cutaneous synthesis when half of the rachitic children were aged between 6 to 15 years, 7-dehydrocholesterol in the skin is converted to with a mean of 8.61+4.07 years. Almost all of the cholecalciferol (vitamin D3) by the ultraviolet-B respondents were from low family income group. Subjects radiation². Calcium supplementation with or without were primarily children of parents with low level of vitamin D heals rickets more rapidly in children than does education.
    [Show full text]
  • B Disorders of Autonomic Nervous System
    Application of the International Classification of Diseases to Neurology \ Second Edition World Health Organization Geneva 1997 First edition 1987 Second edition 1997 Application of the international classification of diseases to neurology: ICD-NA- 2nd ed. 1. Neurology - classification 2. Nervous system diseases - classification I. Title: ICD-NA ISBN 92 4 154502 X (NLM Classification: WL 15) The World Health Organization welcomes requests for permission to reproduce or translate its publications, in part or in full. Applications and enquiries should be addressed to the Office of Publications, World Health Organization, Geneva, Switzerland, which will be glad to provide the latest information on any changes made to the text, plans for new editions, and reprints and translations already available. ©World Health Organization 1997 Publications of the World Health Organization enjoy copyright protection in accordance with the provisions of Protocol 2 of the Universal Copyright Convention. All rights reserved. The designations employed and the presentation of the material in this publication do not imply the expression of any opinion whatsoever on the part of the Secretariat of the World Health Organization concerning the legal status of any country, territory, city or area or of its authorities, or concerning the delimitation of its frontiers or boundaries. The mention of specific companies or of certain manufacturers' products does not imply that they are endorsed or recommended by the World Health Organization in preference to others of
    [Show full text]